• Fluorescein TSA Fluorescence System Kit Guide

  2026-09-02

  The Fluorescein TSA Fluorescence System Kit uses HRP-catalyzed deposition of fluorescein-labeled tyramide to improve localization of low-abundance targets in fixed samples. Product specifications define fluorescein excitation at 494 nm, emission at 517 nm, and distinct storage conditions for the kit components.

• MRSA Extracellular Vesicles Activate IL-8 in OSCC

  2026-09-02

  A 2026 Journal of Advanced Research study identifies methicillin-resistant Staphylococcus aureus extracellular vesicles as active drivers of oral squamous cell carcinoma growth through an IL-8–CXCR1 signaling relay. By combining MRSA-versus-MSSA vesicle comparisons, pathway inhibition, genetic validation, and mouse tumor experiments, the work offers a mechanistic framework for studying antibiotic-resistant bacteria in cancer biology.

• NHS-Biotin Workflows for Protein Detection

  2026-09-02

  NHS-Biotin provides covalent, amine-directed labeling for antibody detection, purification, and compact intracellular assays. This guide also shows how biotinylation can support quality control around peptidisc-assembled nanobody polybodies without confusing labeling with multimerization.

• Lisinopril Dihydrate: Assay-Ready ACE Inhibition

  2026-09-01

  Lisinopril dihydrate is a long-acting ACE inhibitor for mechanistic cardiovascular and renal studies. This guide focuses on assay interpretation, peptidase selectivity, formulation control, and translational model design rather than repeating a conventional product overview.

• 3X (DYKDDDDK) Peptide in V-ATPase Assays

  2026-08-31

  Learn how the 3X (DYKDDDDK) Peptide supports selective detection, affinity workflows, and mechanistic interpretation of dynamic V-ATPase assembly experiments.

• Tomivosertib Suppresses Human DRG Ectopic Activity

  2026-08-31

  Li et al. tested the MNK inhibitor tomivosertib directly in cultured human dorsal root ganglion neurons obtained during spinal surgery. At 25 nM, the compound rapidly and reversibly reduced spontaneous activity in neurons associated with painful dermatomes, while altering eIF4E phosphorylation and electrophysiological properties.

• JSH-23: NF-κB Inhibitor Workflow

  2026-08-30

  JSH-23 enables pathway-level testing of NF-κB p65 nuclear localization and transcription without directly blocking IκB degradation. This makes it useful for macrophage inflammation research, pathway-discrimination studies, airway infection assays, and translational kidney-injury models.

• H. pylori–HNF4A Silencing Drives Gastric Cancer

  2026-08-29

  A 2025 Cell Death and Disease study identifies promoter hypermethylation of HNF4A as a mechanistic link between Helicobacter pylori infection, epithelial polarity loss, EMT activation, and gastric cancer progression. Its integrated clinical, single-cell, cellular, and in vivo evidence positions HNF4A methylation as a testable axis in cancer epigenetics and gastric tumor biology.

• Amikacin Disulfate: From Ribosome to Assay Design

  2026-08-28

  Amikacin disulfate is a mechanistically informative 16S rRNA-targeting antibiotic for studying bacterial protein synthesis suppression and resistance. This article connects ribosome-centered assays with orthogonal protein-binding methods, showing how to separate molecular binding, structural change, and functional loss.

• Reparixin: From IL-8 Biology to Translational Proof

  2026-08-28

  A translational framework for using Reparixin, a CXCR1/2 inhibitor, to connect MRSA extracellular-vesicle signaling with tumor biology, neutrophil behavior, and tissue injury while maintaining clear experimental boundaries.

• Salinomycin: Measuring HCC Drug Response Precisely

  2026-08-28

  Salinomycin is a polyether ionophore antibiotic whose effects in hepatocellular carcinoma models require more than a single viability readout. This article presents an assay strategy that separates growth arrest, cell death, ion-homeostasis changes, and pathway modulation for more interpretable research conclusions.

• Carboplatin Workflows for DNA Damage Research

  2026-08-27

  Build reproducible Carboplatin dose–response, DNA synthesis, and resistance assays across ovarian, lung, and triple-negative breast cancer models. The workflow pairs practical formulation guidance with a mechanistic strategy for studying cancer stem-like cells and FZD1/7-linked resistance.

• DAPI and the Microbiome: From Nuclei to Translation

  2026-08-26

  The Prevotella copri–IPyA–UHRF1–AMPK axis reframes breast cancer progression as a microbiome-linked metabolic problem. DAPI adds a practical phenotypic layer, helping translational teams connect nuclear integrity, cell fate, and mechanistic pathway studies without overstating what a DNA stain can prove.

• Coelenterazine for Brain–Kidney Reporter Design

  2026-08-26

  Coelenterazine can do more than generate luciferase light: it helps researchers separate reporter activity, oxidative chemistry, and physiological outcome. This article develops an assay-design framework inspired by brain–kidney axis research and defines where ROS readouts are informative—and where they are not.

• Ridaforolimus in Cancer and Senescence Assays

  2026-08-26

  Ridaforolimus, also called Deforolimus or MK-8669, provides a precise way to interrogate mTOR-dependent growth, metabolism, VEGF output, and treatment response. This practical guide connects concentration-controlled cancer assays with machine-learning-inspired senescence workflows while emphasizing selectivity controls and troubleshooting.

8565 records 1/571 page Next 12345 下5页 Last page